Delivery Order SPE2DB22D3004-SPE2DB25FSE63
Award Date 8/27/25
Potential Completion Date 8/28/25
Potential Value $1.8K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,376.18 to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Lidocaine HCL 1% 50 mg/5 mL vials (5 mL quantity). The award is firm fixed price with no set-aside designation, reflecting a competitive procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor and will perform work at its corporate office location. This delivery order is issued under...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,437.99 to AmerisourceBergen Drug Corp for Lidocaine HCL 1% vials (10 mL) on August 13, 2025, with an ultimate completion date of August 14, 2025. The contract utilizes firm fixed pricing with no set-aside designation and is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Lidocaine HCL 2% 200 mg/10 mL vials totaling $3,408.68 with a completion date of August 13, 2025. This is a firm fixed-price, non-set-aside contract with performance at the company's Conshohocken, Pennsylvania facility. The delivery order represents a child contract action under AmerisourceBergen's larger Indefinite Delivery Contract with DLA...
- The Defense Logistics Agency awarded a $1,903.04 delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Lidocaine HCL 1% 50 mg/5 ml vials (5 ml). This firm fixed-price delivery order, which represents a non-set-aside competitive award, is scheduled for completion by July 28, 2025, with performance based in Conshohocken, Pennsylvania. The contract leverages AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.9...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp's Corporate Office division in Conshohocken, Pennsylvania. The $1,623.22 order is for the supply of Lidocaine HCL 4% Solution in 4 mL vials. This delivery order is part of a larger, single-award indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp with DLA, valued at up to $999,999,999.00 through December 31, 2025. The IDC serves as the primary contract vehicle for...
- AmerisourceBergen Drug Corp was awarded a delivery order for Lidocaine HCL 50ML (25 units) valued at $1,360.90 under a firm fixed price contract with the Defense Logistics Agency's Medical Supply Chain, a defense-focused federal agency. The award, issued on August 13, 2025, with an ultimate completion date of August 13, 2025, represents a non-set-aside competitively awarded contract. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Lidocaine HCL 4% Solution 4ML. The contract has a ceiling value of $2,356.29 and a completion date of July 8, 2025. It is a firm fixed-price contract, without any set-aside designation. Amerisourcebergen Drug Corp is the prime contractor, and this delivery order is part of a larger Indefinite Delivery Contract (IDC) with the DLA...
- The Defense Department, through its Medical Supply Chain division, awarded a delivery order valued at $1,712.10 to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Lidocaine HCL in 50ML quantities (25 units). The contract employs firm fixed pricing with no set-aside designation, indicating competitive award based on open competition. Performance will be executed at the contractor's Corporate Office location in Conshohocken, Pennsylvania, with an ultimate completion date of...
- The U.S. Defense Logistics Agency (DLA) awarded a $22,692.39 firm fixed-price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the provision of 4% Lidocaine HCL Solution (4 ml). The contract has an ultimate completion date of May 4, 2023. This delivery order is issued under Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. The IDC serves...
- The Defense Logistics Agency awarded a $1,387.67 firm fixed price delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Lidocaine 0.8% in D5W Solution in 250ml units. The delivery order, with an ultimate completion date of July 25, 2025, represents a single-day fulfillment requirement for this pharmaceutical product. This award was made without a set-aside designation, indicating it was competitively awarded through open procurement processes. The place of performance...